| 3.88 Data as of 4:00pm ET |  +0.16 / +4.30%Today’s Change | 2.93 Today|||52-Week Range 9.20 | -49.94% Year-to-Date |
| Previous close | 3.72 |
| Today’s open | 3.72 |
| Day’s range | 3.71 - 4.05 |
| Volume | 106,449 |
| Average volume (3 months) | 66,998 |
| Market cap | $139.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -114.71% |
| Earnings growth (this year) | -955.00% |
| Earnings growth (next 5 years) | +7.55% |
| Revenue growth (last year) | +1.16% |
| P/E ratio | NM |
| Price/Sales | 3.56 |
| Price/Book | 1.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| HZNPHorizon Pharma Inc | +0.07 | +3.11% |
| AVEOAveo Pharmaceuticals... | -0.03 | -1.13% |
| OGXIOncoGenex Pharmaceut... | +0.05 | +0.50% |
| OMEROmeros Corp | +0.21 | +4.23% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $61.3M |
| Annual profit (last year) | -$1.4M |
| Net profit margin | -2.30% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Cooper Pearce |
Senior Vice President-Research & Development Brian T. Dorsey |
Corporate headquarters The Woodlands, Texas |
.
